Company Clal Biotechnology Industries Ltd.

CBI

IL0011042806

Investment Holding Companies

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Other Holding Companies

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 15:24:13 16/05/2024 BST			5-day change	1st Jan Change
49.9 ^ILa	-2.73%		-0.60%	+25.69%

03-31	Clal Biotechnology Industries Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Clal Biotechnology Industries Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Clal Biotechnology Industries Ltd (CBI) is an Israel-based biotechnology investment company. CBI's investments are targeted at bio-pharmaceutical companies, which are at different stages of research and development. The Company is a 59%-owned subsidiary of Clal Industries and Investments Ltd. (CII) that is part of IDB group. Clal Biotechnology Industries Ltd. has a number of portfolio companies, namely Andromeda Biotech Ltd., engaged in the field of type 1 diabetes; D-Pharm Ltd and Trombutech, engaged in the field of ischemic stroke; Mediwound Ltd., engaged in burn and wound management; Biokine Ltd, Biocancell Ltd and CureTech, engaged in the field of cancer; Braintact, engaged in the CNS field and Polyheal Ltd, engaged in wound management, among others.

ILS in Million	2021	Weight	2022	Weight	Delta
Investment and Related Activities 100.0 %	132	100.0 %	18	100.0 %	-86.35%

ILS in Million	2021	Weight	2022	Weight	Delta
Israel 100.0 %	132	100.0 %	18	100.0 %	-86.35%

Managers	Title	Age	Since
Assaf Segal CEO	Chief Executive Officer	51	30/06/15
Liat Nissan DFI	Director of Finance/CFO	46	-
Arnon Aharon CTO	Chief Tech/Sci/R&D Officer	55	31/12/21
Jonathan Eilat IRC	Investor Relations Contact	-	-
Joshua Hazenfratz AUD	Comptroller/Controller/Auditor	70	14/05/07
Iris Sadeh AUD	Comptroller/Controller/Auditor	-	31/12/11

Members of the board	Title	Age	Since
Avraham Matityahu Fischer CHM	Chairman	67	08/05/03
Yuval Yanai BRD	Director/Board Member	71	17/11/15
Gad Keren BRD	Director/Board Member	73	16/02/20
Gabriel Barbash BRD	Director/Board Member	74	24/03/03
Tomer Efraim Babai BRD	Director/Board Member	39	04/12/17
Nufar Malovani BRD	Director/Board Member	46	18/11/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	161,256,549	55,870,242 ( 34.65 %)	4,410,349 ( 2.735 %)	34.65 %

Name	Equities	%	Valuation
Ayalon Mutual Funds Ltd. 0.2936 %	460,433	0.2936 %	58 595 ILa
KSM Mutual Funds Ltd. 0.0749 %	117,475	0.0749 %	14 950 ILa
Migdal Mutual Funds Ltd. 0.0388 %	60,933	0.0388 %	7 754 ILa
Ramco Mutual Funds Management (1989) Ltd. 0.0282 %	44,239	0.0282 %	5 630 ILa
Excellence Nessuah Mutual Funds Management Ltd. 0.0233 %	36,523	0.0233 %	4 648 ILa
Halman Aldubi Mutual Funds Ltd. 0.0105 %	16,543	0.0105 %	2 105 ILa
Menora Mivtachim Mutual Funds Ltd. 0.0102 %	15,995	0.0102 %	2 036 ILa
Edmond de Rothschild Mutual Fund Management Ltd. 0.002755 %	4,321	0.002755 %	550 ILa
U-Bank Mutual Funds Ltd. 0.000427 %	669	0.000427 %	85 ILa

Name	Equities	%	Valuation
GAMIDA CELL LTD. 1.68%	2,581,746	1.68%	46,471 $

Clal Biotechnology Industries Ltd.

Triangle Building Azrieli Center 3

67023, Tel Aviv

http://www.cbi.co.il

address Clal Biotechnology Industries Ltd.(CBI)

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Other Holding Companies

	1st Jan change	Capi.
CLAL BIOTECHNOLOGY INDUSTRIES LTD.	+25.69%	21.17M
INVESTOR AB	+19.09%	79.51B
KOÇ HOLDING	+71.72%	18.81B
INVESTMENT AB LATOUR	+11.40%	17.62B
AB INDUSTRIVÄRDEN	+10.25%	14.64B
L E LUNDBERGFÖRETAGEN AB	+3.79%	13.24B
HAL TRUST	+6.33%	11.88B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+7.01%	11.11B
MERITZ FINANCIAL GROUP INC.	+37.73%	10.61B
GROUPE BRUXELLES LAMBERT SA	+0.18%	10.02B

Other Holding Companies